60 related articles for article (PubMed ID: 7074602)
1. Cytotoxic antibody reactivity in sera of melanoma patients against allogeneic and autologous cultured tumor cells and fibroblasts.
Brown JM; Shoffner PC; Tondreau SP; Matthews EJ; Terry WD; Rosenberg SA
Cancer Res; 1982 Jun; 42(6):2216-22. PubMed ID: 7074602
[No Abstract] [Full Text] [Related]
2. Production of antisera with specificity for malignant melanoma and human fetal skin.
Fritze D; Kern DH; Drogemuller CR; Pilch YH
Cancer Res; 1976 Feb; 36(2 Pt 1):458-66. PubMed ID: 56991
[TBL] [Abstract][Full Text] [Related]
3. Augmentation of autologous antibody to human melanoma following acid dissociation and ultrafiltration of serum.
Kirkwood JM; Vlock DR
Cancer Res; 1984 Sep; 44(9):4177-82. PubMed ID: 6744327
[TBL] [Abstract][Full Text] [Related]
4. Clinical and immunological significance of human melanoma cytotoxic antibody.
Bodurtha AJ; Chee DO; Laucius JF; Mastrangelo MJ; Prehn RT
Cancer Res; 1975 Jan; 35(1):189-93. PubMed ID: 1109788
[TBL] [Abstract][Full Text] [Related]
5. Levels of cytotoxic reactivity to cultured normal skin fibroblasts in sera from normal and sarcoma-bearing patients.
Catapano MS; Brown JM; Rosenberg SA
Cancer Res; 1980 Apr; 40(4):979-83. PubMed ID: 6928402
[TBL] [Abstract][Full Text] [Related]
6. Use of the antibody-dependent cellular cytotoxicity test to detect antibodies in sera of breast cancer patients.
Plain MJ; Whitehead RH; Jose DG
J Natl Cancer Inst; 1981 Apr; 66(4):619-24. PubMed ID: 7014964
[TBL] [Abstract][Full Text] [Related]
7. "Hidden" cytotoxic antibodies that react with allogeneic cultured fetal and tumor cells contained in soluble immune complexes from normal human sera.
Morgan AC; Rossen RD; McCormick KJ; Stehlin JS; Giovanella BC
Cancer Res; 1982 Mar; 42(3):881-7. PubMed ID: 7059986
[TBL] [Abstract][Full Text] [Related]
8. 707-AP peptide recognized by human antibody induces human leukocyte antigen A2-restricted cytotoxic T lymphocyte killing of melanoma.
Takahashi T; Irie RF; Nishinaka Y; Hoon DS
Clin Cancer Res; 1997 Aug; 3(8):1363-70. PubMed ID: 9815820
[TBL] [Abstract][Full Text] [Related]
9. [In vitro humeral serum cytotoxic reactions in melanoma].
Korosteleva TA; Veresova OV; Khachaturyan LM
Vopr Onkol; 1979; 25(9):12-4. PubMed ID: 483712
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of specific serologic reactivity in human osteosarcoma.
Sindelar WF
Cancer; 1983 Feb; 51(3):444-51. PubMed ID: 6185204
[TBL] [Abstract][Full Text] [Related]
11. Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2.
Mogi S; Ebata T; Setoguchi Y; Fujime M; Heike Y; Kohsaka T; Yagita H; Okumura K; Azuma M
Clin Cancer Res; 1998 Mar; 4(3):713-20. PubMed ID: 9533541
[TBL] [Abstract][Full Text] [Related]
12. Lysis of human solid tumors by autologous cells sensitized in vitro to alloantigens.
Strausser JL; Mazumder A; Grimm EA; Lotze MT; Rosenberg SA
J Immunol; 1981 Jul; 127(1):266-71. PubMed ID: 7195411
[TBL] [Abstract][Full Text] [Related]
13. Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells.
Zennadi R; Abdel-Wahab Z; Seigler HF; Darrow TL
Cell Immunol; 2001 Jun; 210(2):96-105. PubMed ID: 11520076
[TBL] [Abstract][Full Text] [Related]
14. Study on the complement-dependent cytotoxic effect of the sera of hamsters bearing transplanted melanoma.
Kozłowska K; Zurawska-Czupa B; Kostulak A
Arch Immunol Ther Exp (Warsz); 1985; 33(3):435-42. PubMed ID: 4062508
[TBL] [Abstract][Full Text] [Related]
15. Recognition of gp43 tumor-associated antigen peptide by both HLA-A2 restricted CTL lines and antibodies from melanoma patients.
Takahashi T; Irie RF; Morton DL; Hoon DS
Cell Immunol; 1997 Jun; 178(2):162-71. PubMed ID: 9225007
[TBL] [Abstract][Full Text] [Related]
16. Reactivity of autologous CD4+ T lymphocytes against human melanoma. Evidence for a shared melanoma antigen presented by HLA-DR15.
Takahashi T; Chapman PB; Yang SY; Hara I; Vijayasaradhi S; Houghton AN
J Immunol; 1995 Jan; 154(2):772-9. PubMed ID: 7814883
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies to human tumor antigens.
Steplewski Z
Transplant Proc; 1980 Sep; 12(3):384-7. PubMed ID: 7222217
[No Abstract] [Full Text] [Related]
18. Serologic analysis of human tumor antigens. II. Reactivity of sera from eleven osetogenic sarcoma patients against autologous and allogeneic tumor cells.
Rosenberg SA; Tondreau SC; Shoffner PC; Hyatt C; Brown JM; Thorpe W; Sindelar W
Surgery; 1979 Aug; 86(2):258-65. PubMed ID: 288177
[TBL] [Abstract][Full Text] [Related]
19. Reduced efficacy of allogeneic versus syngeneic fibroblasts modified to secrete cytokines as a tumor vaccine adjuvant.
Aruga A; Aruga E; Chang AE
Cancer Res; 1997 Aug; 57(15):3230-7. PubMed ID: 9242454
[TBL] [Abstract][Full Text] [Related]
20. Detection of cell-surface antigens of bovine ocular squamous cell carcinoma.
Atluru D; Kleinschuster SJ; Zupancic ML; Muscoplat CC
Am J Vet Res; 1982 Jul; 43(7):1156-9. PubMed ID: 7103194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
